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As we commemorate the 30th anniversary of the Campylobacter, Helicobacter, and
Related Organisms (CHRO) workshops with this special Frontiers edition, we look
back upon three decades of research and provide some highlights from the 16th
International CHRO meeting. Although Theodor Escherich himself provided drawings of
campylobacters back in the 1880s, Campylobacter jejuni was not identified until the 1950s.
Helicobacter pylori was first described to be the causative agent of stomach ulcers at a
CHRO meeting by Barry Marshall and Robin Warren—who later received the Nobel Prize
for their findings that bacteria could cause diseases previously believed to be caused
by human factors. Now, several genome sequences for campylobacters, helicobacters,
and related organisms are available and we have moved into an era examining the
intersection between host microbial ecology and pathogen infection. Both pioneers and
new investigators in the CHRO research field continue to obtain “unexpected results”
demonstrating that campylobacters and helicobacters do not follow classic paradigms
of other well-characterized gastrointestinal pathogens and we are learning that there is
a plethora of interesting related organisms beyond C. jejuni and H. pylori. This review
summarizes recent discoveries in CHRO research and the exciting directions ahead.
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biology, host responses, pathogenesis
INTRODUCTION
Campylobacter, Helicobacter, and Related Organisms (CHRO)
researchers from around theworld gathered inVancouver, Canada
in August, 2011 to share their history and exciting new findings
on this unique group of microorganisms. Martin Skirrow and
Martin Blaser regaled the audience during the opening session
with historical stories of CHRO research, while Roger Feldman
and James Fox provided perspectives on the future of CHRO
research at the gala closing banquet. Three CHRO field leaders
co-chaired the Young Investigator Award session—Skirrow,
Hubert Endtz, and Thomas Meyer—providing inspiration to the
future generations of CHRO researchers. And there were many
highly interactive sessions describing new discoveries in between.
The calibre of science presented at CHRO 2011, in oral and
poster presentations, was exceptional. For space purposes, this
review covers an overview of select oral presentations that both
reflect emerging general themes and provide additional details
on certain focal points. Also, for confidentiality purposes, only
published data and unpublished data for which we have received
permission from the authors are described in detail, while general
topics are noted for other areas of interest.
GENOMES AND EMERGING SPECIES
William Miller, an expert in CHRO sequencing, provided a
comparative summary of 30 fully sequenced Campylobacter
taxa—and this number will soon reach 40—in addition to
describing nine sequenced Arcobacters (also described by Sarah
De Smet) and Sulfurosprillum delayianum. It is becoming more
and more apparent that other members of this group of epsilon-
proteobacteria are capable of causing disease; most have just
not been accounted for due to culturing limitations. But, for
Campylobacter species, Albert Lastovica’s Cape Town protocol is
becoming more and more widespread and demonstrating that
organisms such as C. concisus (discussed by Nadeem Kaakoush
and Hans Nielsen) and C. upsaliensis (pathogenesis described
by Shauna Crowley/Christine Szymanski) are emerging species.
CHRO researchers are also using non-culture-based methodolo-
gies such as PCR to detect these organisms in food and fecal
samples, so the epidemiology, host range, and virulence prop-
erties of many Campylobacter species is yet to be determined.
For example, Olivier Vandenberg described the use of 16S-PCR-
DGGE to determine the role of epsilon-bacteria in children
with abdominal complaints. Linda Mansfield provided a com-
prehensive overview of emerging Campylobacter species, while
Lori Graham and Samuel Sheppard described new methods to
differentiate and study C. fetus and C. coli, pathogens that are
typically isolated from farm animals. There are also greater than
10 Helicobacter species sequenced. Bram Flahou described the
non-H. pylori helicobacters (NHPH), such as H. suis that are also
found in the stomach of both humans and pigs, and cause disease
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despite lacking H. pylori virulence factors such as the vacuolating
toxin VacA and the cag pathogenicity island (cagPAI) that encodes
the type IV secretion pathway.
GENOMIC DIVERSITY
Both campylobacters and helicobacters are capable of varying the
on/off status of several proteins allowing for the best adapted
phenotype to predominate under a given selection pressure. One
commonmechanism of phase variation is through slipped-strand
mispairing, where repeats of DNA (in the case of helicobacters
and campylobacters, typically homopolymeric tracts of Gs or
Cs) are either shortened or lengthened during DNA replication
or repair resulting in premature stop codons in the translated
protein. Genomic sequencing has identified many phase-variable
genes in both genera—and there have been several reports in
the literature about the consequences of varying bacterial surface
structures. This is especially evident for C. jejuni where individual
stocks of strain 11168 from different labs display different capsu-
lar polysaccharide (CPS) structures, and as such Brendan Wren
appropriately called this organism “a moving target.” Generally
speaking, there are also multiple gene products that influence
motility in C. jejuni, thus demonstrating whether a mutation
affects motility requires vigorous analysis since the random rate
of this event is high—similarly, the motility of the population
needs to be confirmed before doing any adherence/invasion or
colonization studies since motility has been repeatedly shown
to influence these phenotypes. For H. pylori, there are 46 genes
prone to slipped-strandmispairing andmany elegant studies have
demonstrated the variation in O-antigen Lewis structures in the
lipopolysaccharides (LPS), for instance, has a role in both host
immune responses and bacterial colonization ability.
H. pylori faces multiple conditions in the gut such as pen-
etrating the host mucous and tolerating high acid levels. The
organism must also confront host inflammatory mediators and
has a limited number of two-component signal transduction sys-
tems that commonly allow bacteria like E. coli to move between
niches. Instead, evidence suggests that H. pylori uses genetic
diversity for adaptation. Jay Solnick described how H. pylori
can “tune” the host inflammatory response and adapt to the
varying conditions in this environment in order to establish a
chronic infection. Solnick talked about different mechanisms of
genetic diversity and variation of BabA (ABO blood group adhe-
sion) and other virulence factors. Sebastian Suerbaum further
discussed mechanisms forH. pylori diversity including mutation-
generating single nucleotide polymorphisms (SNPs) and recom-
bination. Remarkably, H. pylori genomes are “sequence mosaics”
and Suerbaum suggested they may actually be used as a method
to trace human migrations. Suerbaum then demonstrated
that DNA imports showed significantly increased frequency in
the members of the protein family which includes the Bab
proteins.
Since C. jejuni is naturally competent similar to H. pylori,
Eduardo Taboada pointed out that there are multiple mech-
anisms for strain variation including exchange of genes and
entire clusters by horizontal gene transfer, gene duplication, dele-
tion, fusion, and contingency gene variation, while Christopher
Bayliss described exciting new means to detect phase-variable
genes. Similarly, Lone Brondsted in collaboration with Szymanski
described a study, published in this issue, examining the role
of bacteriophage selection on C. jejuni CPS structure. Chickens
were infected with a C. jejuni strain expressing phosphoramidate
(MeOPN) on its CPS with or without a C. jejuni phage recog-
nizing MeOPN. Six days later, pooled populations of C. jejuni
from phage uninfected birds still expressed the MeOPN, were
phage sensitive, and the MeOPN transferase gene showed 9 Gs
(“ON”). In contrast, C. jejuni isolated from the phage-infected
birds lacked MeOPN (in all cases except one where another
phase variant was isolated), were phage resistant, and sequenc-
ing showed 8 or 10 Gs (“OFF”). Remarkably, the same level of
C. jejuni colonization was observed in all chickens demonstrat-
ing that phage resistance does not always lead to an attenuated
phenotype.
CONTROL MEASURES FOR Campylobacter jejuni
Qijing Zhang, Albert Lastovica, Hubert Endtz, and Patrick
Kwan all presented results demonstrating that antibiotic resis-
tance is increasing for C. jejuni and Francis Megraud showed
similar trends for H. pylori. However, research is on-going
to determine the molecular basis for C. jejuni resistance as
Monika Keelan and Declan Bolton described. And scientists
are using different approaches for antimicrobial development
against C. jejuni including using CmeABC efflux pump inhibitors
(Zhang), systems biology approaches (Mark Reuter and Arnoud
van Vliet), and components of bacteriophages (Muhammad
Javed/Szymanski). Birthe Hald presented a 4-year study on the
effects of fly screens in poultry houses in Denmark and showed
that screens significantly reduced flock prevalence of C. jejuni.
Nigel French also demonstrated that a significant reduction in
human cases was observed after introducing poultry interven-
tions. Interestingly, although the majority of urban cases are
associated with poultry, rural cases appear to be correlated with
cattle and other environmental sources. TrudyWassenaar empha-
sized that more work is needed to determine the numbers of
infectious campylobacters in the environment and their source
of contamination. Clarence Tam presented data from the infec-
tious intestinal disease (IID) 2 study showing that the incidence
of campylobacter in the UK has not changed in the last 15 years,
while Jaap Wagenaar showed data from the European BIOHAZ
group, and Birgitte Borck summarized the European CamCon
project. In addition to providing a bigger-picture perspective,
Julian Davies, an expert in the field of antibiotics and resis-
tance, likewise echoed many of these sentiments in his talk and
proposed novel, small molecule-based antimicrobial strategies in
the future.
GLYCOBIOLOGY
Brendan Wren started this session with a prediction that C. jejuni
will become better known for the birth of bacterial glycoengi-
neering than as a notorious foodborne pathogen. His comments
are based on the findings that C. jejuni was the first bacterium
shown to possess an N-linked protein glycosylation pathway and
that this pathway can be functionally transferred into E. coli.
This resulted in the emergence of GlycoVaxyn, founded in 2004,
and based on using the C. jejuni N-glycosylation machinery to
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create novel bacterial glycoconjugate vaccines. Two talks in this
session described the characterization of N-glycan pathways in
other Campylobacter species (Harald Nothaft/Szymanski) and
in related organisms such as Wolinella succinogenes (Jonathan
Butler/Dennis Linton). Jos van Putten showed that C. jejuni
N-glycans and some forms of lipooligosaccharides (LOS) are rec-
ognized by carbohydrate receptors on dendritic cells and may
be able to modulate the host immune response. Then, Susan
Logan described the process for O-linked protein glycosylation
in both C. jejuni and H. pylori and the need for these gly-
can structures for proper flagellar filament assembly and sub-
sequent motility. Due to the importance of flagella for both
organisms, it is not surprising that small molecule inhibitors of
the O-glycan pathway are being pursued. Interestingly, bacte-
rial flagella are common pathogen-associated molecular patterns
(PAMPs) that are recognized by Toll-like receptor (TLR)-5, but
both H. pylori and C. jejuni evade this response. van Putten
demonstrated that modification of C. jejuni flagella withO-linked
glycans is not the mechanism for evasion, instead they identi-
fied a new β-hairpin structure involved in recognition. Stephen
Trent described a new modification associated with the flagel-
lar apparatus. Phosphoethanolamine is typically transferred to
the LOS/LPS core of many bacteria including C. jejuni and
H. pylori. The Trent group demonstrated that the C. jejuni
phosphoethanolamine transferase not only modifies the LOS,
but also the flagellar rod protein, FlgG. Mutation of the trans-
ferase results in abnormal flagellar filament assembly and reduced
antimicrobial peptide resistance. Other forms of phosphorylated
modifications were identified on the surface of C. upsaliensis:
phosphoramidate on the CPS and phosphocholine on the LOS
(Shauna Crowley/Szymanski), and data were presented demon-
strating that both these modifications could contribute to bac-
terial survival and pathogenesis. Craig Parker described draft
genomes of 56 C. jejuni and C. coli isolates and compared the
LOS and CPS loci noting all the genetic mechanisms for diversity
and some commonalities among the strains. Although H. pylori
does not have anN-glycan pathway like C. jejuni, Mario Feldman
showed that the H. pylori flippase was evolutionarily connected
to the C. jejuni N-glycan pathway and is used for flipping LPS
O-antigens into the periplasm. Feldman also demonstrated that
using the C. jejuni N-glycan enzymes and the H. pylori fucosyl-
transferase together with enzymes from Haemophilus influenzae,
he could engineer H. pylori Lewis antigens for the treatment of
specific autoimmune diseases. Eleonora Altman, on the other
hand, is interested in creating a vaccine against H. pylori and
wants to avoid the Lewis antigens which mimic human Lewis
structures. She has discovered a common α-1,6-glucan chain in
clinical isolates ofH. pyloriwhich is now being explored. Jonathan
Lane provided a different perspective to the glycobiology session
when he discussed the use of sugars to inhibit bacterial binding.
This would indeed be an inexpensive therapeutic, but various
C. jejuni strains would need to be compared since it is known
that C. jejuni infection in developing countries results in dif-
ferent disease symptoms. Also, Hubert Endtz reported that in
their rural Bangladesh studies, breastfeeding (breastmilk contains
large amounts of potentially anti-infective oligosaccharides) did
not prevent disease in children in the 0–6 month range.
Helicobacter pylori : CagA, VacA, AND HOST RESPONSES
CHRO 2011 saw a resurgence of presentations on Helicobacter
biology and pathogenesis. In the areas of H. pylori patho-
genesis and host interactions, a number of key advances on
the Cag pathogenicity island (PAI) encoding a type IV secre-
tion system were described. As Masanori Hatakeyama intro-
duced, the CagA effector is injected into host cells, becomes
tyrosine-phosphorylated by host cell oncoproteins, and mim-
ics a host cell factor to activate or inactivate specific intra-
cellular signaling pathways. In his presentation, Hatakeyama
described the identification of several mammalian proteins con-
taining CagA’s critical EPIYA phosphorylation site motif, one
of which was competitively inhibited by CagA for downstream
events. This suggested that H. pylori acquired CagA to subvert
one or more endogenous eukaryotic EPIYA-containing proteins
to establish successful infection. Additional expert perspective
on the impact of the cagPAI on host responses was provided
by Thomas Meyer. Furthermore, three new protein components
of the Cag type IV pilus that do not have homologs in other
bacteria but are nonetheless required for CagA translocation
into host cells and downstream events, such as IL-8 induction,
were described by Carrie Shaffer/Timothy Cover, lending fur-
ther insight into novel means by which H. pylori interacts with
host cells.
A number of talks also addressed the intersection of CagA and
iron. Manuel Amieva used live-cell microscopy data and other
techniques to demonstrate that one of CagA’s functions is to
aid in iron acquisition from the host, and that this function is
required both for microcolony formation on intercellular junc-
tions and for colonization of gerbils. The model of iron-replete
vs. iron-deplete gerbils described by Amieva was also used by
his collaborators Jennifer Noto/Richard Peek, who showed that
iron depletion significantly increased the frequency and severity
of H. pylori-induced disease, including carcinoma, in a CagA-
dependent manner. Noto and Peek’s work also suggested that
regulation of H. pylori virulence factors by iron availability con-
tributes to these findings, a theme mirrored by D. Scott Merrell’s
presentation showing connections between CagA and the ferric
uptake regulator Fur. Merrell’s group found that Fur positively
regulates CagA expression via a Fur box in the cagA promoter and
that Fur is most important in early stages of infection. All three of
these presentations clearly show that iron availability and acqui-
sition play a critical role in H. pylori disease etiology, mediated at
least in part by CagA.
Advances in understanding roles for the vacuolating cyto-
toxin VacA in pathogenesis were also presented. In addition to
his CagA work, Manuel Amieva described how VacA influences
the pathogen-host iron homeostasis via inducing mislocaliza-
tion of the host epithelial cell transferrin receptor. VacA’s striking
effect on mitochondrial morphology was addressed by Steven
Blanke, who presented work demonstrating VacA’s activation of
a host cell dynamin-related protein (Drp1) and the relationship
of this activation to uncoupling of mitochondrial fission and
fusion and induction of apoptosis. Blanke further hypothesized
that these events aidH. pylori colonization by crippling cells at the
epithelial barrier, rendering them less fit to respond to H. pylori
infection.
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Additional insight into mechanisms underlying host responses
to H. pylori infection was provided by three different presen-
tations. In one talk, James Neal/Karen Guillemin showed that
transgenic zebrafish expressing CagA displayed early intestinal
proliferation, adult intestinal hyperplasia, and activation of the
Wnt pathway, further indicative of a key role for CagA in
H. pylori-induced carcinogenesis. A connection between H. pylori
chemotaxis and immune responses was demonstrated by Annah
Rolig/Karen Ottemann, who showed that chemotaxis mutants
were defective for early gastric recruitment of CD4+ T cells
and induction of a Th17 immune response component impli-
cated in apoptosis. As this is the first study showing an effect
of bacterial chemotaxis on apoptosis, these findings will likely
have relevance for other systems as well. Finally, Anne Mueller’s
talk addressed an intriguing paradox: namely, that persistent
infection with H. pylori is linked to protection from allergic,
chronic inflammatory, and autoimmune disease. Using an asthma
model, Mueller showed an interconnection between H. pylori
infection, immune cell responses, and reprogramming of den-
dritic cells toward a tolerance-promoting state. Mueller further
hypothesized that this beneficial aspect of H. pylori infection
may contribute to persistence of H. pylori among the human
population.
Campylobacter jejuni : NEW ANIMAL MODELS PROVIDE
INSIGHT INTO HOST AND BACTERIAL FACTORS
MEDIATING DISEASE
A number of diverse topics were covered in sessions pertaining to
C. jejuni pathogenesis, host responses, and host cell interactions.
In addition to Patricia Guerry’s overview of the contribution of
CPS to virulence, various aspects of the C. jejuni-host cell interac-
tion were described by Dennis Kopecko, Nicole Iovine, Dominic
Mills/Nick Dorrell, and Lieneke Bouwman/Jos van Putten.
Furthermore, a number of new connections between the LOS
and/or sialylation and Guillain-Barré Syndrome were drawn by
Ruth Huizinga, Arnoud van Vliet, and Astrid Heikema/Janneke
Samsom.
An emerging area of interest, covered by two talks, is the util-
ity of new or recently developed small animal models of disease
in exploring C. jejuni disease markers and identifying new host
and bacterial factors important for disease etiology. Christian
Jobin used IL-10−/− mice expressing GFP from the NF-κB pro-
moter, which develop invasive, campylobacteriosis-like colitis, to
explore host signaling pathways involved in C. jejuni-induced
inflammation. Daily injections with rapamycin allowed C. jejuni
to colonize the intestine but prevented extra-intestinal dissem-
ination and inflammation, implicating the mammalian mTOR
pathway specifically in disease. Additional experiments suggested
these effects were independent of T-cell activation, suggesting
mTOR signaling components as possible targets for new treat-
ments. Markus Heimesaat described the development, along with
co-author Stefan Bereswill, of a new gnotobiotic mouse model
harboring “humanized” gut flora. C. jejuni stably colonized
these mice and elicited a pro-inflammatory immune response
that was dependent on the host innate immune receptors TLR4
and TLR9, and on C. jejuni formate dehydrogenase utilization
genes.
IN THE NICHE: INTERACTION OF CHRO WITH MICROBIAL
COMMUNITIES AND SURVIVAL STRATEGIES IN DIVERSE
ENVIRONMENTS
An emerging theme in CHRO research, and indeed in bacterial
pathogenesis, is the interaction of CHRO and other “infecting”
bacteria with resident microbial communities. This was intro-
duced at CHRO 2011 by Brett Finlay, who described research
in his laboratory dissecting the interplay between E. coli and
Samonella with gutmicroflora, and is also of relevance to the find-
ings described above by Heimesaat and colleagues regarding their
humanized gut flora mouse model of C. jejuni-mediated inflam-
mation. TwoH. pylori talks also addressed this topic. Richard Peek
discussed this from the perspective of microbial and host diver-
sity, and the contribution of each to stomach cancers. Peek noted
that in addition to contributions of H. pylori intra- and inter-
genomic diversity, H. pylori exist in a distinct gastric microbial
ecosystem which may provide an additional genetic pool allow-
ing H. pylori to develop traits further influencing its propensity
to cause gastric cancers. Also noted were findings showing that
host factors modulating immunity, and thus presumably also
the microflora composition, likewise impact gastric cancer risks.
AnicaWandler/Guillemin presented new results from a transgenic
Drosophila model showing that intestinal expression of CagA
alters the composition of the gutmicrobiome, further implicating
CagA in new areas ofH. pylori-host biology.
Survival strategies, primarily in the form of stress responses,
were also discussed in the context of life “in the niche.” Arnoud
van Vliet, in a talk entitled “Try not to breathe . . .,” provided
an overview of how the microaerophilic C. jejuni counters var-
ious oxygen concentrations ranging from virtually anaerobic to
atmospheric (aerobic) as it moves from niche to niche, as well
as conditions caused by reactive oxygen species. van Vliet also
noted that C. jejuni forms enhanced biofilms in aerobic condi-
tions. Andrew Cameron/Erin Gaynor presented the first global
characterization of the response of C. jejuni to hyper-osmotic
conditions, some of which are encountered during host colo-
nization. Finally, Alain Stintzi discussed the PerR regulon as a
means by which C. jejuni counters oxidative stress, as well as how
C. jejuni acquires iron, the importance of iron-related genes in
colonization, and regulation of those genes by the regulator Fur.
FUNDAMENTAL BIOLOGY OF CHRO: BACTERIAL CELL
SHAPE, METABOLISM, AND CHEMOTAXIS
Also new to the CHRO workshop was a session dedicated
to research on basic bacterial processes. Well-suited to this
theme were two talks exploring means by which H. pylori and
C. jejuni derive their helical shape, and the ramification of
shape/peptidoglycan alterations on other important processes.
Nina Salama described the first characterization of shape-related
genes in H. pylori. Deletion mutants displayed a variety of shape
abnormalities ranging from “s” and “c” shapes with exagger-
ated curvature to straight rods. Some of the proteins involved,
termed “Csd” for “cell shape determinant,” are novel peptido-
glycan peptidases, while others perform other cellular functions.
Salama proposed two independent peptidoglycan modification
networks, demonstrated roles for each of the csd genes in a mouse
model of colonization, and described models for how each shape
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change affects H. pylori motility. An independent screen in
C. jejuni, described by Emilisa Frirdich/Gaynor, also identified
a peptidoglycan peptidase (“Pgp”) as the first factor to impact
C. jejuni shape. Deletion of this gene resulted in a straight rod
morphology, modest motility and biofilm defects, peptidogly-
can that hyper-activated the intracellular innate immune recep-
tor Nod1, and a defect in chick colonization. This gene was a
homolog of an unpublished H. pylori csd described by Salama,
deletion of which also caused a straight rod phenotype, and the
specific enzymatic activity of each protein on peptidoglycan was
determined. The work by Frirdich/Gaynor also provided the first
muropeptide map for C. jejuni.
Dave Kelly presented a comprehensive talk on numerous
aspects of C. jejuni metabolism. One was the C. jejuni strain-
dependent utilization of select amino acids as growth substrates,
and his group’s recent observation that exogenous peptides can
provide a source of amino acids. Kelly also described the highly
complex and branched respiratory chains in C. jejuni, that new
types of electron donors and acceptors distinct from those in
other bacteria have recently been identified, and the depen-
dence on the twin-arginine transporter (TAT) system for deliv-
ery of many important respiratory enzymes to the periplasm
(and thereby dependence on the TAT system for the ability of
C. jejuni to respire on substances requiring those enzymes).
Hilde De Reuse presented data on the role of the pleiotropic
H. pylori nickel-dependent regulator NikR to activate or repress
important target genes such as ureA and hydA, which in turn
encode urease and hydrogenase for which nickel is a co-factor
and which are essential for H. pylori colonization. De Reuse
showed that NikR-dependent repression occurred at higher
nickel concentrations than activation, suggesting a chrono-
logical hierarchy and elaborate mechanisms for NikR target
discrimination.
Chemotaxis in both C. jejuni and H. pylori was also discussed.
Victoria Korolik presented findings on the first C. jejuni sen-
sory receptor, Tlp1, re-named CcaA for its role as an aspartate
receptor, and its role in motility, colonization, and cell inva-
sion. As Kelly noted, aspartate is a major amino acid used as a
C. jejuni carbon source, emphasizing the importance of CcaA to
C. jejuni biology. Korolik further showed that for CcaA, signal
transduction occurs via binding to CheV and not CheW, sug-
gesting differences in this pathway from other enteric pathogens.
Karen Ottemann described the chemotactic program inH. pylori,
the phosphorylation-based signal transduction cascade, how the
H. pylori system differs from that of E. coli and Bacillus subtilis,
and other findings on newer components involved in H. pylori
chemotaxis.
FUTURE PERSPECTIVES
These are exciting times in CHRO research—in the past, we have
looked toward E. coli and Salmonella for understanding bacterial
physiology—now campylobacter and helicobacter have become
model systems for understanding bacterial glycobiology, survival
in mucin, metabolism of microaerophiles, and the importance of
cell shape and motility. There is also a growing appreciation for
the importance of CHRO other than C. jejuni and H. pylori, and
as such it is anticipated that we will learn much more about these
organisms and their possible roles in human/animal health and
disease. Although we were unable to highlight all of the oral talks
or the outstanding poster presentations, we look forward to the
next few years of CHRO publications. There is a bright future
ahead for CHRO research, and we would particularly like to high-
light the Young Investigator Award winners: Cody Buchanan,
Jonathan Butler, Ilana Cohen, Shauna Crowley, Rajinder Dubb,
David Hermans, Laura MacRitchie, Ana Martins, Dominic Mills,
James Neal, Jennifer Noto, and Christian Penny. We look forward
to many CHROmeetings to come.
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